AntonioAbbateMD

Cardiology • Charlottesville, VA

Exercise Physiology and Cardiac Rehabilitation, Cardiac Critical Care

Professor of Medicine University of Virginia

Join to view full profile

Dr. Abbate is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abbate's full profile

Already have an account?

Office
415 Lane Rd
Charlottesville, VA 22908
Phone+1 434-297-9449

Education & Training

Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2004 - 2007
OtherClass of 2000

Certifications & Licensure

VA State Medical License 2004 - 2024
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Anakinra to Prevent Post-infarction Remodeling Start of enrollment: 2008 Nov 01
Completed
Phase 3
Anakinra to Prevent Adverse Post-infarction Remodeling (2) Start of enrollment: 2010 Jul 01
Completed
Phase 2
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2012 Feb 01
Completed
Not Applicable
Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP) Start of enrollment: 2013 Apr 01
Completed
Not Applicable
Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction Start of enrollment: 2013 Dec 01
Completed
Phase 1, Phase 2
Interleukin-1 Blockade in Recently Decompensated Heart Failure Start of enrollment: 2014 Feb 01
Completed
Phase 2, Phase 3
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest Start of enrollment: 2013 Sep 01
Completed
Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3) Start of enrollment: 2014 Jul 01
Completed
Phase 2, Phase 3
Interleukin-1 Blockade in HF With Preserved EF Start of enrollment: 2014 Sep 01
Completed
Phase 2
Alirocumab in Patients With Acute Myocardial Infarction Start of enrollment: 2017 Jan 01
Completed
Phase 4
SP16 SERPIN-like Peptide Administration in Healthy Individuals Start of enrollment: 2018 Jul 16
Completed
Phase 1
Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2 Start of enrollment: 2019 Jan 04
Recruiting
Phase 2
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis Start of enrollment: 2020 Oct 23
Recruiting
Phase 2
SP16 Inflammatory Response Inhibition Trial Start of enrollment: 2020 Feb 24
Completed
Phase 1, Phase 2
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation Start of enrollment: 2020 Sep 02
Completed
Phase 2
Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis Start of enrollment: 2023 Dec 01
Not yet recruiting
Phase 2, Phase 3
Roles: Contact
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure Start of enrollment: 2022 May 24
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

41 citations
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study.
Nicola Potere, Marcello Di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari
Annals of the Rheumatic Diseases. 2021-02-01
44 citations
The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches.
Adolfo G Mauro, Aldo Bonaventura, Alessandra Vecchié, Eleonora Mezzaroma, Salvatore Carbone
JACC. Basic to Translational Science. 2021-02-01
105 citations
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Allan L Klein, Massimo Imazio, Paul Cremer, Antonio Brucato, Antonio Abbate
The New England Journal of Medicine. 2021-01-07

Journal Articles

The Present and Future JACC State-of-the-Art Review Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review
F Gerard Moeller, Antonio Abbate, ScienceDirect